• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

Task force, guidelines target low testosterone in men

Article

Rapidly increasing usage of TRT in the absence of good scientific data is the impetus for the formation of a multidisciplinary task force, led by the Institute of Medicine and supported by the NIA. The task force will make recommendations about the design, safety, and ethics of clinical trials to evaluate the risks and benefits of TRT, including whether such studies are even warranted. The AACE recently updated its guidelines for the treatment and evaluation of hypogonadism. The updated guidelines are intended to serve as a source of guidance for healthcare professionals. The document is also an appeal to clinicians to increase their awareness of hypogonadism, and to discuss the issue with their at-risk patients.

Related Content
woman awake holding glass near alarm clock

FDA Approves New Insomnia Therapy: What Pharmacists Need to Know

January 21st 2022
Article

Daridorexant is approved to treat insomnia in adults who have difficulty with sleep onset or maintenance.

pills in a pill bottle

Acetaminophen Reduces Opioid Treatment Duration, Study Shows

January 6th 2022
Article

Clinicians are seeking ways to reduce opioid exposure in a variety of settings. Could the use of acetaminophen before opioid use reduce opioid treatment duration in the inpatient setting?

health care finances on screen and selection options

Price Competition As Result of New Drug Approval

January 3rd 2022
Article

The FDA approved efgartigimod, which is being sold under the brand name Vyvgart and could foment price competition with Soliris (eculizumab) and other treatments usually reserved for severe or refractory cases.

figure of brain scan

Targeted Drug Combination Reveals New Activity in Brain Tumors

December 28th 2021
Article

A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.

pill and virus

FDA Issues EUA for First Oral Antiviral Pill for COVID-19

December 22nd 2021
Article

The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.

probiotics

Probiotics for Candidiasis and Vaginosis in the Clinical Setting

December 16th 2021
Article

The benefits of probiotics do not necessarily transfer to the clinical setting for vulvovaginal candidiasis, according to a recent review.

© 2023 MJH Life Sciences

All rights reserved.